Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125783661 | 12578366 | 1 | I | 20160111 | 20160721 | 20160721 | PER | PL-MLMSERVICE-20160112-0131808-1 | PL-LUPIN PHARMACEUTICALS INC.-2016-00399 | LUPIN | URBAN A, WIGLUSZ M, CUBALA W, LANDOWSKI J, KRYSTA K. RAPID-ONSET AGRANULOCYTOSIS IN A PATIENT TREATED WITH CLOZAPINE AND LAMOTRIGINE. PSYCHIATRIA DANUBINA. 2015;27 (1):459-461. | 60.00 | YR | F | Y | 0.00000 | 20160721 | OT | PL | PL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125783661 | 12578366 | 1 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | 450 MG | UNKNOWN | 0 | |||||||||
125783661 | 12578366 | 2 | PS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | Y | UNKNOWN | 78691 | 25 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125783661 | 12578366 | 1 | Schizophrenia |
125783661 | 12578366 | 2 | Schizophrenia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125783661 | 12578366 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125783661 | 12578366 | Agranulocytosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |